REDUCE YOUR RADIATION EXPOSURE WITH TEXRAY

REDUCE YOUR RADIATION EXPOSURE WITH TEXRAY

THE HEART AND SOUL OF TEXRAY

Texray has developed the first radiation protection textile in the world, to address the need for improved radiation protection for medical professionals. The patented technology platform is currently used in novel products, designed to reduce scatter radiation during fluoroscopy-guided interventions.

PHANTOM STUDY

There is no cut-off point for radiation-induced DNA damage. Texray patented innovations reduce scatter with up to 90% additional dose reduction, concluded by a recent phantom study published in CVIR.¹⁵∙¹⁶

CLINICAL EVALUATION

Prof S. Rohde and Dr F. Bärenfänger, Dortmund Germany, recently performed a scientific assessment of Texray novel head protectors concluding dose reduction up to 97%.¹⁴

CONTACT YOUR LOCAL DISTRIBUTOR

We are represented by Distributors in most EU, UK and ESS countries. We also have distributors in Japan and UAE. If you are resident in a country not listed, please get in contact with us directly.

TESTIMONIALS

NEWS

  • Published On: March 25, 2025
    Texray Files For Its 10th Patent; Announcing Groundbreaking Expansion of Product Portfolio
  • Published On: March 3, 2025
    Texray Expands U.S. Presence by Appointing a Chief Commercial Officer
  • Published On: November 12, 2024
    Texray Receives Notice of Allowance for U.S. Patent Application, Strengthening Innovation and Market Leadership
  • Published On: October 31, 2024
    Texray Announces Nationwide Distribution Agreement with OneTwo Medical, UK
  • Published On: September 2, 2024
    Prof. Jim A. Reekers hosts Texray Radiation Protection Session CIRSE Congress
  • Published On: July 15, 2024
    Texray Welcomes Andrew Werner as Chief Operating Officer